Safety and Efficacy of ARQ-154 Foam in Subjects With Seborrheic Dermatitis
Trial details
- Registry ID
- NCT04091646
- Phase
- Phase 2
Drug identity checked against registry records
Also recorded as Placebo
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Safety and Efficacy of ARQ-154 Foam in Subjects With Seborrheic DermatitisNCT04091646 | ARQT | Phase 2 | Completed | 2020-08-18Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |